Kong Min, Jin Jiang, Cai Xiuyu, Shen Jianfei, Ma Dehua, Ye Minhua, Zhu Chengchu, Freedman Samuel, Walters Kelly, Xu Xin, Chen Baofu
Department of Cardiothoracic Surgery, Taizhou Hospital of Zhejiang Province, Wenzhou Medical University, Linhai, Zhejiang State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center Department of Cardiothoracic Surgery, the First Affiliated Hospital of Guangzhou Medical University Guangzhou Institute of Respiratory Disease & China State Key Laboratory of Respiratory Disease, Guangzhou, China Rosalind Franklin University of Medicine and Science, USA.
Medicine (Baltimore). 2017 Dec;96(48):e8870. doi: 10.1097/MD.0000000000008870.
The aim of this study was to retrospectively analyze the clinical data of resected adenosquamous lung cancer (ASLC) and to explore the influencing factors and clinicopathological characteristics of the metastasis lymph nodes. A total of 1156 consecutive patients with surgically resected lung cancer from January 2009 to June 2014 were studied. Fifty-four previously diagnosed ASLC patients were re-evaluated by experienced pathologists. IHC and H&E staining were employed to examine the primary focus and metastasis lymph nodes. The relationship between lymph node metastasis and clinicopathological characteristics of ASLC patients was then analyzed and the pathological type of metastasis lymph node was also determined. Forty-nine cases of typical ASLC were included in the study. Of the 49 ASLC patients, 26 cases presented lymph node metastasis. Lymph node metastasis was not associated with gender, smoking, tumor distribution, histological type of primary focus, and preoperative CEA level, but was associated with age ≥ 65 (P < .05) and tumor size ≥ 3 cm (P < .05). Lymph node metastasis adenocarcinoma was the main type in ASLC patients, and was related to the age and tumor size of the primary focus. Further large sample studies are necessary to identify influencing factors and clinicopathological characteristics of metastasis lymph nodes.
本研究旨在回顾性分析手术切除的肺腺鳞癌(ASLC)的临床资料,探讨转移淋巴结的影响因素及临床病理特征。对2009年1月至2014年6月期间连续1156例行手术切除肺癌的患者进行研究。由经验丰富的病理学家对54例先前诊断为ASLC的患者进行重新评估。采用免疫组化(IHC)和苏木精-伊红(H&E)染色检查原发灶和转移淋巴结。分析ASLC患者淋巴结转移与临床病理特征的关系,并确定转移淋巴结的病理类型。本研究纳入49例典型ASLC病例。49例ASLC患者中,26例出现淋巴结转移。淋巴结转移与性别、吸烟、肿瘤分布、原发灶组织学类型及术前癌胚抗原(CEA)水平无关,但与年龄≥65岁(P<0.05)和肿瘤大小≥3 cm(P<0.05)有关。淋巴结转移腺癌是ASLC患者的主要类型,且与原发灶的年龄和肿瘤大小有关。需要进一步进行大样本研究以明确转移淋巴结的影响因素及临床病理特征。